LVTX LAVA Therapeutics
- 1.040
- -0.070-6.31%
LAVA Therapeutics News
LAVA Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
LAVA Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
No Data